Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
Pan, Chen, Zhang et al. investigated the anti-cancer efficacy of CA170, a small molecule agonist of VISTA, on mouse lung tumorigenesis. When combined with a MHCII-directed KRAS peptide vaccine, the authors reported that CA170 suppressed lung tumor development by increasing CD8+ T cell and decreasing...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25463f045f454089abc25f6e7b64cc74 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:25463f045f454089abc25f6e7b64cc74 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:25463f045f454089abc25f6e7b64cc742021-12-02T16:17:27ZInhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA10.1038/s42003-021-02381-x2399-3642https://doaj.org/article/25463f045f454089abc25f6e7b64cc742021-07-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-02381-xhttps://doaj.org/toc/2399-3642Pan, Chen, Zhang et al. investigated the anti-cancer efficacy of CA170, a small molecule agonist of VISTA, on mouse lung tumorigenesis. When combined with a MHCII-directed KRAS peptide vaccine, the authors reported that CA170 suppressed lung tumor development by increasing CD8+ T cell and decreasing MDSC and Treg infiltration, while the Kras vaccine induced CD4+ effector T cell expansionJing PanYao ChenQi ZhangAchia KhatunKatie PalenGang XinLi WangChuanjia YangBryon D. JohnsonCharles R. MyersShizuko SeiRobert H. ShoemakerRonald A. LubetYian WangWeiguo CuiMing YouNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Biology (General) QH301-705.5 |
spellingShingle |
Biology (General) QH301-705.5 Jing Pan Yao Chen Qi Zhang Achia Khatun Katie Palen Gang Xin Li Wang Chuanjia Yang Bryon D. Johnson Charles R. Myers Shizuko Sei Robert H. Shoemaker Ronald A. Lubet Yian Wang Weiguo Cui Ming You Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA |
description |
Pan, Chen, Zhang et al. investigated the anti-cancer efficacy of CA170, a small molecule agonist of VISTA, on mouse lung tumorigenesis. When combined with a MHCII-directed KRAS peptide vaccine, the authors reported that CA170 suppressed lung tumor development by increasing CD8+ T cell and decreasing MDSC and Treg infiltration, while the Kras vaccine induced CD4+ effector T cell expansion |
format |
article |
author |
Jing Pan Yao Chen Qi Zhang Achia Khatun Katie Palen Gang Xin Li Wang Chuanjia Yang Bryon D. Johnson Charles R. Myers Shizuko Sei Robert H. Shoemaker Ronald A. Lubet Yian Wang Weiguo Cui Ming You |
author_facet |
Jing Pan Yao Chen Qi Zhang Achia Khatun Katie Palen Gang Xin Li Wang Chuanjia Yang Bryon D. Johnson Charles R. Myers Shizuko Sei Robert H. Shoemaker Ronald A. Lubet Yian Wang Weiguo Cui Ming You |
author_sort |
Jing Pan |
title |
Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA |
title_short |
Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA |
title_full |
Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA |
title_fullStr |
Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA |
title_full_unstemmed |
Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA |
title_sort |
inhibition of lung tumorigenesis by a small molecule ca170 targeting the immune checkpoint protein vista |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/25463f045f454089abc25f6e7b64cc74 |
work_keys_str_mv |
AT jingpan inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT yaochen inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT qizhang inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT achiakhatun inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT katiepalen inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT gangxin inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT liwang inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT chuanjiayang inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT bryondjohnson inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT charlesrmyers inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT shizukosei inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT roberthshoemaker inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT ronaldalubet inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT yianwang inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT weiguocui inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista AT mingyou inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista |
_version_ |
1718384219662581760 |